SPOTLIGHT: Did US aid cuts break the things we need most for the lenacapavir roll-out?

South Africa has introduced lenacapavir, a novel long-acting injectable medication offering a promising new avenue for HIV prevention. The rollout of this significant public health tool, however, faces potential challenges. Questions are being raised about the capacity to effectively distribute lenacapavir, given the disruption to established aid delivery networks previously supported by the United States.

The successful implementation of lenacapavir is crucial for advancing HIV prevention efforts in South Africa and could serve as a model for other regions facing similar public health challenges.